Prospective evaluation of a telmisartan suppression test as a diagnostic tool for primary hyperaldosteronism in cats.

Maxime Kurtz,Virginie Fabrès,Renaud Dumont,Valérie Chetboul,Sabine Chahory,Vittorio Saponaro, Emilie Trehiou,Camille Poissonnier,Peggy Passavin,Coline Jondeau,Matthieu Bott,Thierry Buronfosse,Ghita Benchekroun

Journal of veterinary internal medicine（2023）

引用 0|浏览4

暂无评分

摘要

The oral telmisartan suppression test using a single dose of 2 mg/kg telmisartan did not discriminate cats with PHA from healthy middle-aged cats or cats with diseases that may result in secondary hyperaldosteronism.

查看译文

关键词

primary hyperaldosteronism,telmisartan suppression test

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要